| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |